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Natural killer T (NKT) cells are CD1d-restricted, lipid antigen–reactive T cells 
with powerful immunoregulatory potential. The prototypic antigen for NKT 
cells is a marine sponge–derived glycolipid, -galactosylceramide (-GalCer), 
but this is not normally encountered in the mammalian environment. Thus, 
there is great interest in the identification of more physiological stimuli for 
NKT cells, and numerous studies have shown that NKT cells are capable of 
responding to a range of microbial lipid-based antigens. Two new studies 
expand our understanding of environmental NKT cell stimuli, with one showing 
that CD1d-restricted NKT cell antigens are present within common house dust 
extract (HDE), whereas the other shows that NKT cells can respond to innate 
stimuli irrespective of the presence of foreign microbial antigens. Collectively, 
these two investigations indicate that NKT cells are far more likely to encoun-
ter foreign antigens, or innate activating signals, than previously recognized, 
suggesting a more central role for these cells in the immune system.
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NKT cells are lipid antigen (Ag)–reactive, 
CD1d-restricted  T cells that express a lim-
ited array of  T cell receptors (TCRs). 
The most widely studied NKT cells are 
known as type 1 or classical NKT cells. 
They are present in mice and humans 
and are defined by their expression of 
an invariant TCR- chain (V14-J18 
in  mice  and  V24-J18  in  humans) 
paired with particular TCR-V chains 
(V2, 7, or 8 in mice and V11 in 
humans).  Type  1  NKT  cells are also 
characterized by their ability to recog-
nize the prototypic CD1d-restricted 
glycosphingolipid Ag -GalCer, which 
is a marine sponge–derived compound 
that has potent immunoregulatory po-
tential. Type 2 NKT cells are distinct 
from type 1 NKT cells in that they express 
a more diverse TCR repertoire; these 
cells recognize CD1d-restricted lipid Ags 
such as sulfatide, but they do not recog-
nize -GalCer (Godfrey et al., 2010b). 
Although type 2 NKT cells are likely to 
have a unique and important role in the 
immune system, the remainder of this   
article will focus on type 1 NKT cells.
The growing repertoire of NKT  
cell antigens
For many years, immunologists strug-
gled to explain the existence of a highly 
conserved T cell lineage that appeared 
to  be  specific  for  Ags  derived  from   
such a seemingly innocuous source as ma-
rine sponges. However, it is now clear 
that NKT cells are activated by naturally 
occurring microbial Ags such as -gluc-
uronosylceramide and -galacturonosyl-
ceramide from Sphingomonas spp. (Kinjo 
et al., 2005; Mattner et al., 2005; Sri-
ram  et  al.,  2005),  -galactosyldiacyl-
glycerol from Borrelia burgdorferi (Kinjo 
et al., 2006), phosphatidylinositol-man-
nosidase from Mycobacterium bovis BCG   
(Fischer et al., 2004), -glucosyldiac-
ylglycerol from Streptococcus pneumoniae 
(Kronenberg, M., personal communica-
tion), and a cholesteryl -glucoside from   
Helicobacter pylori (Chang et al., 2011). 
Furthermore, NKT cells can also respond 
to self-lipid–based  Ags, including -linked 
glycosphingolipids -galactosylceramide 
(-GalCer), -glucosylceramide (-
GlcCer), isoglobotrihexosylceramide 
(iGb3), and disialoganglioside, as well as 
self-phospholipid Ags such as phospha-
tidylethanolamine,  phosphatidylinosi-
tol, and phosphatidylcholine (Godfrey 
et al., 2010a; Venkataswamy and Porcelli, 
2010). Thus, NKT cells may be busier 
than initially realized in dealing with a 
broad range of Ags from a variety of 
different sources, both exogenous and   
endogenous. There is also great interest 
in the use -GalCer derivatives that have 
the potential to skew NKT cell–mediated 
responses toward Th1 or Th2 directions, 
which may lead to tailored NKT cell–
based immunotherapy (Venkataswamy 
and Porcelli, 2010). Remarkably, the 
NKT  TCR  seems  to  recognize  this 
diverse range of Ags by acting as a pat-
tern recognition receptor in which the 
docking  of  NKT  TCR-CD1d-Ag  is 
conserved, regardless of the V usage 
(Borg et al., 2007; Scott-Browne et al., 
2007; Pellicci et al.,  2009;  Mallevaey   
et al., 2011).
Two papers in the latest issue of JEM 
provide  critical  new  insight  into  the 
physiological factors that activate NKT 
cells. In one paper, Wingender et al.  
demonstrates that NKT cells respond to 
Ags present in environmentally ubiqui-
tous HDE. In the second paper, Brigl  
et al. provides evidence that the NKT 
cell response to a diverse range of bacte-
rial  infections  appears  to  occur  in  a   
microbial Ag-independent and an IL-12– 
and Toll-like receptor (TLR)–dependent 
manner, even when the infectious or-
ganisms produce NKT cell Ags (Fig. 1).
CD1d-restricted NKT cell antigens  
in common HDE
HDE  contains  immunoregulatory   
adjuvant-like  factors  that  can  either 
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is  reminiscent  of  some  earlier  studies   
(Michel  et  al.,  2007;  Pichavant  et  al., 
2008; Umetsu and Dekruyff, 2010). The 
critical questions that arise from these 
studies  are  whether  HDE-mediated 
NKT cell stimulation promotes asthma 
in humans, and what is the nature of the 
HDE  Ags  involved?  Although  NKT 
cells are present in the lungs of asth-
matic humans, the extent to which they 
are involved in disease is unclear and con-
troversial (Thomas et al., 2010; Umetsu 
and Dekruyff, 2010). Both mouse and 
human NKT cells responded to HDE 
samples, and there was a rough correla-
tion  between  the  response  of  mouse 
and human NKT cells to each fraction, 
although some samples preferentially 
stimulated human or mouse NKT cells 
(Wingender et al., 2011). Furthermore, 
the hierarchy of HDE sample potency 
varied between different NKT cell hy-
bridomas  expressing  different  NKT 
TCR-Vs, suggesting the presence of 
more  than  one  NKT  stimulatory Ag 
within HDE and that NKT TCR-V 
chains determine the affinity for these 
Ags. This is consistent with previous work 
hyperreactivity  and  asthma  (Umetsu 
and Dekruyff, 2010), and airway disease 
can be artificially induced by intranasal 
administration  of  -GalCer  (Meyer   
et al., 2006). However, the physiological 
mechanism of NKT cell activation and 
the identity and role of lipid-based Ags 
in association with such diseases is un-
clear. One study demonstrated the pres-
ence  of  CD1d-restricted  phospholipid 
Ags  (phosphatidylethanolamine  and 
phosphatidylcholine)  derived  from   
allergy-inducing plant pollens, although 
these appeared to favor type 2 NKT cell 
stimulation (Agea et al., 2005), whereas 
the response to HDE as documented by 
Wingender et al. (2011) involved type 1 
NKT cells. Interestingly, despite the fact 
that at least half of NKT cells in naive 
mice  are  CD4
+,  the  majority  of  the 
HDE-responsive NKT cells appeared to 
be  CD4
,  many  of  which  produced   
IL-17 (Wingender et al., 2011). This is 
further  evidence  for  the  existence  of 
functionally distinct NKT cell subsets, 
and may indicate an important role for 
IL-17–producing  NKT  cells  in  this 
model of airway hyperreactivity, which 
enhance or suppress Th2 immune re-
sponses and airway hyperreactivity, de-
pending on the dosing regimen (Ng et al., 
2006; Lam et al., 2008). This suggests that 
components of HDE may be important 
in the development or pathogenesis of 
asthma, but conversely, may also provide 
immunotherapeutic  opportunities  for 
this disease (Ng et al., 2006). Wingender 
et al. (2011) now show that Ags present 
within HDE activate NKT cells in a 
CD1d-restricted, TCR-dependent man-
ner.  Moreover,  NKT  cell  activation  is 
critical for the adjuvant activity of HDE, 
the effects of which were markedly di-
minished in TCR-J18
/ NKT cell–
deficient mice. The NKT cell response 
to HDE resulted in bystander NK cell 
activation, increased airway inflamma-
tion, and a stronger adaptive immune 
response  to  a  model Ag  (ovalbumin) 
that  was  co-administered  with  HDE. 
Furthermore, the adaptive immune re-
sponse to ovalbumin resulted in a positive 
feedback loop that further enhanced the 
NKT cell response. Many studies have 
suggested a role for NKT cells in the 
development or pathogenesis of airway 
Figure 1.  Two pathways of NKT cell acti-
vation in response to common environmen-
tal stimuli. (A) HDE is essentially ubiquitous, 
and most samples were found to contain 
CD1d-restricted Ags (orange hexagons) that are 
recognized by NKT TCRs (Wingender et al., 2011) 
and TLR ligands (brown circles; Batzer et al., 
2007). Both components are important for the 
adjuvant effects of HDE (Batzer et al., 2007; 
Wingender et al., 2011). (B) Some, but not all, 
bacteria carry CD1d-restricted lipid Ags that are 
recognized by NKT TCRs, yet NKT cells respond 
to most bacterial infections. Irrespective of 
whether a particular strain carries these Ags, 
the NKT cell response is dominated by innate, 
TLR, and MyD88-dependent signaling that 
results in IL-12 (green squares)–mediated stim-
ulation of NKT cells, rather than by bacterial 
glycolipid Ag recognition (Brigl et al., 2011). The 
response is also at least partly CD1d dependent, 
again, irrespective of the presence of bacterial 
CD1d-restricted lipid Ags, suggesting the rec-
ognition of self-lipid Ags in conjunction with 
the IL-12–mediated stimulation (Brigl et al., 
2011). Thus, there are at least two pathways for 
NKT cell activation: (1) TCR mediated and (2) cytokine mediated. NKT TCR-mediated recognition of foreign lipid-based Ags presented by CD1d that appears to be 
important for the adjuvant effects of HDE (A), but less so for the response to bacterial infection, whereas innate, inflammatory cytokine–mediated stimulation 
of NKT cells appears to dominate the response to bacterial infection (B). In the context of bacterial infections, NKT cells may concurrently recognize self- (blue 
hexagons) or bacterial (orange hexagons) glycolipids, but regardless, the innate (IL-12– and TLR-mediated) stimuli appear to be critical for NKT cell activation.JEM Vol. 208, No. 6 1123
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NKT cell activation by -GalCer, the 
prototypic foreign NKT cell Ag, has a 
major impact on DC activation and the 
magnitude  and  quality  of  subsequent 
adaptive immune responses (Fujii et al., 
2007; Hermans et al., 2007; Guillonneau 
et al., 2009) that were underway at the 
time of NKT cell activation (Cerundolo 
et al., 2009). Moreover, an enhanced 
adaptive immune response was observed 
in the HDE study by Wingender et al. 
(2011).Thus, Ag-specific NKT cell ac-
tivation might be important for the de-
velopment of adaptive immunity and/or 
immunological  memory  in  infectious 
organisms,  which  was  not  assessed  in 
the study by Brigl et al. (2011). It is clear 
that IL-12 does not promote the full 
spectrum  of  NKT  cell  functionality, 
such as production of IL-4 and possibly 
other  important  factors  (Brigl  et  al., 
2011). Determining the extent to which 
IL-12 and other Ag-independent inflam-
matory stimuli can mimic Ag-dependent 
NKT cell responses, and the downstream 
influence  of  these  innate  signals  on 
adaptive immunity and memory, will be 
an important goal for future studies in 
the field.
Future directions
In addition to demonstrating that NKT 
cells are far more likely to encounter Ags 
or other stimulatory factors than previ-
ously appreciated, these new studies touch 
on some of the key issues in the NKT 
cell field. One study demonstrates how 
NKT cell activation can promote air-
way disease, thus having deleterious effects 
on  the  host  (Wingender  et  al.,  2011), 
whereas the other shows the beneficial 
effects of NKT cells via their importance 
in  microbial  immunity  (Brigl  et  al., 
2011). There are also published examples 
where NKT cells play an immunosup-
pressive rather than immunostimula-
tory  role  (Godfrey  and  Kronenberg, 
2004). This raises the question of whether 
therapeutic NKT cell activation to boost 
antimicrobial or anticancer immunity 
might trigger undesirable side effects, and 
whether there are ways to safely and ef-
fectively  harness  the  potent  immuno-
modulatory potential of these cells? This 
is likely to depend on the type of Ags 
used, and the dose, timing, and context of 
to bacterial glycolipid Ag -glucurono-
sylceramide (GSL-1) was CD1d depen-
dent, but IL-12 and TLR independent, 
and drove both IFN- and IL-4 pro-
duction by NKT cells. In contrast, the 
response to whole bacteria (heat-killed 
or live) was IL-12 and TLR dependent 
and predominantly led to IFN- pro-
duction with little or no IL-4. This in-
cludes  the  response  to  Sphingomonas, 
from which GSL-1 is derived. However, 
a role for CD1d is also important regard-
less  of  whether  the  bacteria  expressed 
NKT cell Ags, probably reflecting a role 
for the recognition of self-glycolipid that 
synergizes with the innate IL-12– and/or 
other TLR-dependent signals. 
These  findings  also  touch  on  the 
HDE  study  (Wingender  et  al.,  2011) 
discussed in the previous section, raising 
the question of whether HDE-derived 
Ags, or self-CD1d–restricted Ags com-
bined with innate signals, are more im-
portant for the NKT cell-dependent 
response to HDE in vivo, which is also 
known to be TLR-dependent (Ng et al., 
2006; Lam et al., 2008). However, pro-
duction of both IFN- and IL-4 in the 
HDE model suggests a more prominent 
role for HDE-derived Ag recognition 
by NKT cells in this model. The precise 
identity of self-glycolipid ligands recog-
nized by NKT cells in association with 
innate signaling remains unclear, but 
-linked glycosphingolipids are good 
candidates (Stanic et al., 2003; Mattner 
et al., 2005; Paget et al., 2007; Salio et al., 
2007; Darmoise et al., 2010). Collectively, 
these data suggest that NKT cell recog-
nition of bacterial Ags, such as GSL-1, is 
at most redundant for their antimicro-
bial function.
This raises the important question 
of why NKT cells express TCRs that are 
highly conserved through evolution from 
mice to humans, with specificity for for-
eign  glycolipid  Ags—this  must  be  of 
some benefit to the host. A simple ex-
planation might be that the existence of 
multiple mechanisms for NKT cell stim-
ulation in response to infection provides 
greater protection. For example, it is pos-
sible that Ag-specific NKT cell activa-
tion is important during stages of the 
antimicrobial immune response different 
than those tested in this study. Indeed, 
showing how the V repertoire shapes 
the responsiveness to lipid Ags (Mallevaey 
et  al.,  2009).  Preliminary  studies  sug-
gested that the Ag activity was not de-
rived from house dust mites, and that it 
was not a glycosphingolipid (Wingender 
et al., 2011). It is possible that the HDE 
Ags are of bacterial origin, and further 
investigations  into  different  HDE 
components are clearly warranted. Re-
gardless of the nature of these Ags, their 
presence in the majority of HDE sam-
ples tested suggests that we are literally 
surrounded  by  CD1d-restricted  NKT 
cell Ags with the potential to exacer-
bate asthma and allergic airway disease. 
Whether NKT cells are also responsible 
for HDE-mediated suppression of AHR 
(Ng et al., 2006; Lam et al., 2008) was not 
investigated in the study by Wingender 
et al. (2011), but will be important to de-
termine as it may represent a novel means 
of immunotherapy.
NKT cells respond to infection  
through innate stimuli, regardless  
of the presence of microbial CD1d-
restricted Ag
NKT  cells  play  an  important  role  in 
many different types of infection, includ-
ing bacteria, viruses, parasites, and fun-
gal pathogens, regardless of whether the 
infectious organisms carry known NKT 
cell Ags (Brigl and Brenner, 2010). Two 
pathways are thought to exist for NKT 
cell activation in response to infection: 
one  where  NKT  cells  are  activated 
through direct recognition of microbial 
glycolipid Ags via their TCR (Kinjo et al., 
2005; Mattner et al., 2005; Sriram et al., 
2005; Kinjo et al., 2006) and another 
that occurs in the absence of known mi-
crobial Ags  because  of  the  ability  of 
NKT cells to respond to innate or inflam-
matory stimuli, possibly in conjunction 
with self-glycolipid Ag recognition (Brigl 
et al., 2003; Mattner et al., 2005; Paget 
et al., 2007; Salio et al., 2007; Brigl and 
Brenner, 2010; Darmoise et al., 2010). 
Brigl  et  al.  (2011)  provide  intriguing 
new data suggesting that innate stimuli 
appear to be the major means of NKT 
cell activation, even with bacteria such 
as Sphingomonas spp. and S. pneumoniae 
that carry known NKT cell Ags. They 
demonstrated that the NKT cell response 1124 Turning on NKT cells | Godfrey and Rossjohn
NKT cell activation. What are the key 
self-Ags that underpin the development 
and  self-reactivity  of  NKT  cells,  and 
what is the relationship between self-
NKT cell Ags and foreign (microbial/
environmental) NKT cell Ags? Do in-
nate signals produced in response to in-
fection result in a different repertoire of 
self-Ags to those involved in NKT cell 
development and maintenance, and is 
this  important  for  self-Ag–mediated 
NKT  cell  stimulation?  What  Ags  are 
responsible for maintaining the evolu-
tionarily conserved NKT TCR speci-
ficity?  Presumably,  these  Ags  have  a 
critical role to play in NKT cell biol-
ogy. Whereas microbial glycolipid Ags 
appear to be the most potent agonists 
for NKT cells, perhaps the ability to 
recognize self-glycolipid Ags such as 
-GalCer,  -GlcCer,  or  iGb3  pre-
sented by CD1d is more important for 
these cells. It is critical that we develop a 
more thorough understanding of the an-
tigenic targets, and the role of the NKT 
TCR and/or other factors in the main-
tenance  and  activation  of  these  cells. 
What are the biological consequences 
of TCR variability within the broader 
NKT cell population, and do microbial 
and/or self-glycolipid Ag-reactive sub-
sets of NKT cells exist? There is a grow-
ing body of evidence to suggest that this 
is the case, even within the classical type 
1 NKT cell pool where TCR- varia-
tions can influence Ag reactivity and 
autoreactivity (Schümann et al., 2006; 
Mallevaey et al., 2009, 2011; Pellicci et al., 
2009; Matulis et al., 2010; Wei et al., 
2006; Wun et al., 2011). Also, despite 
clear differences in -GalCer reactivity 
that distinguishes type 1 and 2 NKT cells, 
do the functions and natural antigenic tar-
gets of these cells otherwise overlap?
Our  understanding  of  NKT  cell 
biology, and our ability to manipulate 
these cells as a form of therapy, is criti-
cally dependent on our understanding of 
the factors that regulate and activate these 
cells. The two studies appearing in this 
issue have shown us that we are sur-
rounded by Ags and other stimuli that 
turn on NKT cells. Now we just need 
to determine the consequences of these 
findings and whether they can be used 
to our advantage.
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